Insulet
Manufacturing · Massachusetts, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
100 Nagog Park, Acton, Massachusetts, Un...Phone Number
(866) 941-0155Website
www.insulet.comRevenue
$2.9 BillionStock Symbol
PODDIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
8
9
1
2
2
2
About Insulet
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.Explore more
Insulet Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Insulet your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Insulet
Earning: See what the market has to say on Insulet recently announced quarterly report
Funding: Get notified immidiatlly once Insulet has new funding data
Insulet, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Insulet launches new products
Check if Insulet has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Insulet is spiking on competitors!
Click to see if Insulet had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Insulet as Masked Content
Find more new buyers
Compare Similar Companies to Insulet
Compare insights from companies similar to Insulet, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Insulet is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Insulet is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Insulet.
Insulet financials insights
Gather financial insights about Insulet, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Stock Offering
$115.5M
2009
Debt
$60M
Insulet Tech Stack
A closer look at the technologies used by Insulet
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Insulet News & Media
Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA Meeting Transcript
Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA Meeting June 8, 2026 11:00 AM EDTCompany...Is Insulet Corporation (PODD) A Good Stock To Buy Now?
Is PODD a good stock to buy? We came across a bullish thesis on Insulet Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PODD. Insulet Corporation’s share was trading at $159.61 as of June 9th. PODD’s trailing and forward P/E were 37.30 and 25.71 respectively according to Yahoo […]Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop ...
STRIVE pivotal trial shows Omnipod 6 achieved strong glycemic outcomes with fewer boluses, across age groups and diabetes types EVOLUTION 3 feasibility study demonstrates improved time in range using a fully closed-loop system for type 2 diabetes that automatically adjusts insulin with no user settings Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced new clinical results highli3 Reasons We’re Fans of Insulet (PODD)
Shareholders of Insulet would probably like to forget the past six months even happened. The stock dropped 54.4% and now trades at $144.10. This might have investors contemplating their next move.
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Insulet
Sign Up For FreeTo access detailed company insights
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple,... Read More
